CD5 positivity was found in 52% of cases but was not significantly associated with PFS (HR 1.9 [CI95% 0.6–6.1], p = 0.26), as previously reported by Murase et al.11Cellular origin was mainly a non‐germinal center type (86%), and high expression level of MYC (57%), BCL2 (87%), or both MYC/BCL2 (43%) appears to be more frequent than in DLBCL NOS. The gene discussed is CD5; the disease is diffuse large B-cell lymphoma.